Significantly improve the speed and quality of Radiology reporting by reducing unnecessary dictation, particularly for ultrasound and DEXA. Imorgon transfers modality measurements into Powerscribe/Fluency/RadAI merge fields/tokens, eliminating manual entry errors.
Imorgon's specialized services offer the following advantages:
- All measurements are always transferred (usually DICOM SR)
- Electronic worksheets capture findings and insert them into Powerscribe/Fluency/RadAI (rather than dictating from a worksheet)
- Worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- Integrate into Epic or other EHRs
- Vendor neutral
- Support to ensure everything continues working
Significant improvement in the overhead of reporting with a quick ROI.
Learn more

TeleRay stands out as the pioneering telehealth and image management solution in the industry. This cloud-based platform enables users to safely exchange medical images with a variety of professionals, including specialists, clinicians, and referring doctors, as well as with patients. Its robust feature set allows for the importation and conversion of both DICOM and non-DICOM images, along with providing query capability and HL7 connectivity. Additionally, it seamlessly integrates with any electronic medical record (EMR) system, and users can access images via an FDA-approved viewer on any device, regardless of location.
The platform offers comprehensive DICOM image migration services, which encompass setup, training, and implementation support. Options for live streaming and remote control of imaging modalities are also available, allowing professionals to effectively collaborate from virtually anywhere.
TeleRay prioritizes security with peer-to-peer health and data communication, and its application includes useful workflow tools such as waiting rooms, multi-call capabilities, call transfers, and image sharing, making it user-friendly and budget-conscious.
Currently, over 3,000 locations utilize our services, including 38 leading medical centers across more than 20 countries, demonstrating our extensive reach and reliability. Discover the benefits of TeleRay by signing up for a free trial today.
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis utilizes MRI technology to effectively differentiate between areas of contrast clearance and accumulation in brain tumor imaging datasets. This sophisticated high-resolution technique significantly improves the insight required for ongoing assessments and decision-making in various medical specialties, such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves obtaining two standard 3D T1-weighted MRIs; the first is captured approximately five minutes after the injection of a standard contrast agent, followed by a second scan taken between 60 to 105 minutes later. By performing a subtraction of the first series from the latter, volumetric maps are generated that distinctly highlight regions of contrast clearance (depicted in blue) and those of contrast accumulation (marked in red). This information empowers healthcare professionals to more accurately gauge the impacts of radiation therapy against the possibility of tumor regrowth, thus facilitating more informed decisions regarding both initial and ongoing treatment strategies. Consequently, this analytical approach not only supports clinical evaluations but also plays a crucial role in enhancing the overall management of patient care in challenging medical scenarios, ultimately leading to improved patient outcomes.
Learn more
BrainSightAI
BrainSightAI stands at the forefront of health technology, leveraging artificial intelligence and machine learning to revolutionize the field of brain mapping via AI-driven connectomics, which facilitates the creation of customized brain maps. The VoxelBox product line utilizes these advanced AI methodologies to generate personalized brain maps, aimed at refining pre-surgical planning and enhancing outcomes for patients grappling with brain tumors and various neurological challenges. Additionally, BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on a spectrum of brain-related ailments, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our primary mission is to advance brain science while enriching the lives of individuals through innovative tools that enhance our comprehension of the human brain. By working closely with healthcare professionals, we aspire to make a meaningful contribution to neurology and the overall quality of patient care, ultimately setting new standards in medical practice. Through our efforts, we hope to foster a brighter future for those affected by neurological conditions.
Learn more